Literature DB >> 10842360

Connexin37 in normal and pathological development of mouse heart and great arteries.

J A Haefliger1, R Polikar, G Schnyder, M Burdet, E Sutter, T Pexieder, P Nicod, P Meda.   

Abstract

Cx37 is a member of the connexin family of gap junction proteins, whose distribution in heart remains controversial. We have generated novel antibodies against Cx37 to investigate this distribution during normal and pathological development in mouse. Using these affinity-purified antibodies, we have detected Cx37 in hearts and aortas of mouse embryos from day 11 ed. onwards. Immunostaining revealed that during prenatal development Cx37 predominated in endothelial and endocardial cells but was also detectable in small amounts in the trabeculated and compact layers of ventricular myocardium, as well as in the mesenchyme of conotruncal ridges and atrioventricular cushions. Cx37 was also differentially expressed in the ascending and descending portions of the embryonic aorta, according to a pattern which differed in the three layers of the vessel wall. Cx37 distribution was altered in both heart and aorta of mice that had been exposed to all-trans retinoic acid at the beginning of foetal development, whether or not these animals subsequently developed a transposition of great arteries. The data indicate that Cx37 is widely distributed in multiple compartments of cardiovascular system, in patterns which are modulated during development, by retinoic acid. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10842360     DOI: 10.1002/(SICI)1097-0177(200006)218:2<331::AID-DVDY7>3.0.CO;2-4

Source DB:  PubMed          Journal:  Dev Dyn        ISSN: 1058-8388            Impact factor:   3.780


  12 in total

1.  Inhibition of endothelial wound repair by dominant negative connexin inhibitors.

Authors:  B R Kwak; M S Pepper; D B Gros; P Meda
Journal:  Mol Biol Cell       Date:  2001-04       Impact factor: 4.138

2.  Heterotypic docking of Cx43 and Cx45 connexons blocks fast voltage gating of Cx43.

Authors:  S Elenes; A D Martinez; M Delmar; E C Beyer; A P Moreno
Journal:  Biophys J       Date:  2001-09       Impact factor: 4.033

3.  Conduction of feedback-mediated signal in a computational model of coupled nephrons.

Authors:  Ioannis Sgouralis; Anita T Layton
Journal:  Math Med Biol       Date:  2015-03-19       Impact factor: 1.854

Review 4.  Connexins in Cardiovascular and Neurovascular Health and Disease: Pharmacological Implications.

Authors:  Luc Leybaert; Paul D Lampe; Stefan Dhein; Brenda R Kwak; Peter Ferdinandy; Eric C Beyer; Dale W Laird; Christian C Naus; Colin R Green; Rainer Schulz
Journal:  Pharmacol Rev       Date:  2017-10       Impact factor: 25.468

Review 5.  Connexin37: a potential modifier gene of inflammatory disease.

Authors:  Marc Chanson; Brenda R Kwak
Journal:  J Mol Med (Berl)       Date:  2007-02-22       Impact factor: 4.599

Review 6.  Connexins participate in the initiation and progression of atherosclerosis.

Authors:  Sandrine Morel; Laurent Burnier; Brenda R Kwak
Journal:  Semin Immunopathol       Date:  2009-04-30       Impact factor: 9.623

Review 7.  Connexins in vascular physiology and pathology.

Authors:  Anne C Brisset; Brant E Isakson; Brenda R Kwak
Journal:  Antioxid Redox Signal       Date:  2009-02       Impact factor: 8.401

8.  ACE2 improves right ventricular function in a pressure overload model.

Authors:  Jennifer A Johnson; James West; Karen B Maynard; Anna R Hemnes
Journal:  PLoS One       Date:  2011-06-10       Impact factor: 3.240

9.  Connexin diversity in the heart: insights from transgenic mouse models.

Authors:  Sander Verheule; Sven Kaese
Journal:  Front Pharmacol       Date:  2013-06-27       Impact factor: 5.810

10.  Role of connexins in human congenital heart disease: the chicken and egg problem.

Authors:  Aida Salameh; Katja Blanke; Ingo Daehnert
Journal:  Front Pharmacol       Date:  2013-06-03       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.